New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Royalty Pharma (RPRX – Research Report), ...

Morris Chestnut stars as Dr. John Watson — yes, Sherlock’s old pal — at the forefront of his own medical procedural.

The pharmaceutical giant sold its flex building at the Imperial Center for $41.1 million to New York-based Lightstone Group, ...

KBC Group NV grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 3,862.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange ...

David O. Watson, the General Counsel of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), recently sold a portion of his holdings ...

Bioxyne lifts revenue 77% QoQ; Radiopharm listed on the Nasdaq in the December quarter; Tryptomine hits key milestones; Quarterly season is nearing its end, triggering a rush from ...

While there is a very civilized debate to be had over reboots, literary appropriations and innovative casting, “Watson” does seem like a mischievous middle finger to anyone with hidebound ...

Search for a state or federal candidate to see the donors and industries that support them. Ballot measures allow voters to vote directly on a law or policy change. Explore the ballot measures ...

Actor Morris Chestnut stars as Dr. John Watson in CBS' new series "Watson," solving medical mysteries while continuing Sherlock Holmes' legacy after his partner's death. The show combines hospital ...

“The canon is always very much with us. The life that Watson had with Sherlock is not done with him,” executive producer Craig Sweeny promises of the new CBS drama starring Morris Chestnut as ...